Search results
Asthma treated in mice using offshoot of CAR T-cell cancer therapy
New Scientist· 11 hours agoIt might be possible to effectively cure the most common form ofasthma by using genetically...
First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential
Benzinga via Yahoo Finance· 5 days agoWednesday, Sanofi SA (NASDAQ:SNY) reported results from the Phase 2 study of oral rilzabrutinib in...
Manage Your Asthma: FDA on Know Your Triggers and Treatment Options
Sierra Sun Times· 6 days agoAsthma is a chronic lung disease that causes the airways to become inflamed and narrow. Symptoms of...
Asthma Triggers In Homes Can Send Kids to the ER—This Organization Is Working to Change That
Health.com· 6 days agoFor parents of children with asthma, witnessing an attack of severe symptoms can be a terrifying...
Sanofi reports positive data from Phase II asthma treatment trial
Clinical Trials Arena via Yahoo Finance· 4 days agotreatment-emergent adverse event (TEAE), with a higher incidence in the rilzabrutinib group versus...
GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows
Benzinga via Yahoo Finance· 6 days agoTuesday, GSK plc (NYSE:GSK) released headline results from the phase III clinical trials SWIFT-1 and...
GSK Experimental Drug Reduces Severe Asthma Attacks in Key Trial
Bloomberg· 6 days agoAn experimental drug from GSK Plc reduced asthma attacks in late-stage trials, paving the way for a ...
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
Zacks via Yahoo Finance· 5 days agoGSK’s GSK two-phase III studies, which evaluated depemokimab for treating severe asthma...
GSK Sees Positive Results for Severe Asthma Treatment Depemokimab
Market Watch· 6 days agoBy Najat Kantouar GSK said that it had positive results from phase III trials of depemokimab, aimed at assessing the drug's efficacy and safety in adults and...
GSK's experimental drug shows promise in reducing severe asthma attacks
Reuters via Yahoo News· 6 days agoThe drug, called depemokimab, showed "significant and meaningful reductions" in asthma attacks for...